KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Vir Biotechnology (VIR) Leases (2020 - 2025)

Vir Biotechnology (VIR) has disclosed Leases for 6 consecutive years, with $62.1 million as the latest value for Q4 2025.

  • Quarterly Leases rose 4.05% to $62.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $62.1 million through Dec 2025, up 4.05% year-over-year, with the annual reading at $62.1 million for FY2025, 4.05% up from the prior year.
  • Leases hit $62.1 million in Q4 2025 for Vir Biotechnology, down from $63.6 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $88.3 million in Q1 2022 to a low of $57.6 million in Q3 2021.
  • Historically, Leases has averaged $70.5 million across 5 years, with a median of $67.6 million in 2024.
  • Biggest five-year swings in Leases: soared 289.96% in 2021 and later dropped 16.91% in 2024.
  • Year by year, Leases stood at $87.2 million in 2021, then dropped by 5.35% to $82.6 million in 2022, then dropped by 13.78% to $71.2 million in 2023, then fell by 16.16% to $59.7 million in 2024, then rose by 4.05% to $62.1 million in 2025.
  • Business Quant data shows Leases for VIR at $62.1 million in Q4 2025, $63.6 million in Q3 2025, and $64.9 million in Q2 2025.